Abstract
Bilayer nicotine mucoadhesive patches were prepared and evaluated to determine the feasibility of the formulation as a nicotine replacement product to aid in smoking cessation. Nicotine patches were prepared using xanthan gum or carbopol 934 as a mucoadhesive polymers and ethyl cellulose as a backing layer. The patches were evaluated for their thickness, weight and content uniformity, swelling behavior, drug–polymers interaction, adhesive properties, and drug release. The physicochemical interactions between nicotine and the polymers were investigated by Fourier transform infrared (FTIR) spectroscopy. Mucoadhesion was assessed using two-arm balance method, and the in vitro release was studied using the Franz cell. FTIR revealed that there was an acid base interaction between nicotine and carbopol as well as nicotine and xanthan. Interestingly, the mucoadhesion and in vitro release studies indicated that this interaction was strong between the drug and carbopol whereas it was weak between the drug and xanthan. Loading nicotine concentration to non-medicated patches showed a significant decrease in the mucoadhesion strength of carbopol patches and no significant effect on the mucoadhesion strength of xanthan patches. In vitro release studies of the xanthan patches showed a reasonable fast initial release profile followed by controlled drug release over a 10-h period.
Similar content being viewed by others
REFERENCES
Yildiz D. Nicotine, its metabolism and an overview of its biological effects. (Review). Toxicon. 2004;43:619–32.
Galanti L. Tobacco smoking cessation management: integrating varenicline in current practice. Vasc Health Risk Manag. 2008;4(4):837–45. PMCID: PMC2597768.
D’Orlando KJ, Fox BS. Tolerability and pharmacokinetics of single and repeated doses of nicotine with the straw, a novel nicotine replacement product. Nicotine Tob Res. 2004;6(1):63–70.
Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray and an inhaler. Arch Intern Med. 1999;159:2033–8.
Park CR, Munday DL. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharmaceut. 2002;237:215–26.
Hao J, Heng P. Buccal delivery systems. Drug Dev Ind Pharm. 2003;29(8):821–32.
Shojaei A. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci. 1998;1(1):15–30.
Xiang J, Fang X, Li X. Transbuccal delivery of 2′, 3′-dideoxycytidine: in vitro permeation study and histological investigation. Int J Pharmaceut. 2002;231:57–66.
Veuillez F, Kalia Y, Jacques Y, Deshusses J, Buri P. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm. 2001;51:93–109.
Swarbrick A. Oral mucosal drug delivery. New York: Marcel Dekker; 1996.
Shin S, Kim J, Oh I. Mucoadhesive and physicochemical characterization of carbopol-poloxamer gels containing triamcinolone acetonide. Drug Dev Ind Pharm. 2000;26(3):307–12.
Park CR, Munday DL. Evaluation of selected Polysaccharide Excipients in buccoadhesive tablets for sustained release of nicotine. Drug Dev Ind Pharm. 2004;30(6):609–17.
Smart JD. Recent developments in the use of bioadhesive systems for delivery of drugs to the oral cavity. Crit Rev Ther Drug Carrier Syst. 2004;21:319–44.
Roubroeks JP, Andersson R, Mastromauro DI, Christensen BE, Aman P. Molecular weight, structure and shape of oat (1 → 3), (1 → 4)-b-d-glucan fractions obtained by enzymatic degradation with (1 → 4)-b-d-glucan 4-glucanohydrolase from Trichoderma reesei. Carbohydr Polym. 2001;46:275–85.
Perez-Marcos B, Gutierrez C, Gomez-Amoza JL, Martinez-Pacheco R, Souto C, Concheiro A. Usefulness of certain varieties of Carbopol in the formulation of hydrophilic furosemide matrices. Int J Pharmaceut. 1991;67(2):113–21.
Lee J, Park J, Robinson R. Bioadhesive-based dosage forms; the next generation. J Pharm Sci. 2000;89:850–66.
Hao J, Paul Heng WS. Buccal delivery systems. Drug Dev Ind Pharm. 2003;29(8):821–32.
Majithiya RJ, Ghosh PK, Umrethia ML, Murthy RS. Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan. AAPS PharmSciTech. 2006;7(3):67. doi:10.1208/pt070367.
Abu-Huwaij R, Assaf S, Salem M, Sallam A. Potential mucoadhesive dosage form of lidocaine hydrochloride: II. In vitro and in vivo evaluation. Drug Dev Ind Pharm. 2007;33(4):437–48.
Patel VM, Prajapati BG, Patel HV, Patel KM. Mucoadhesive bilayer tablets of propranolol hydrochloride. AAPS PharmSciTech. 2007;8(3):77. doi:10.1208/pt0803077.
Tamburic S, Craig D. A comparison of different in vitro methods for measuring mucoadhesive performance. Eur J Pharm Biopharm. 1997;44:159–67.
Parodi B, Russo E, Caviglioli G, Cafaggi S, Bigbardi G. Development and characterization of a buccoadhesive dosage form of oxycodane hydrochloride. Drug Dev Ind Pharm. 1996;22(5):445–50.
Emami J, Varshosaz J, Saljoughian N. Development and evaluation of controlledrelease buccoadhesive verapamil hydrochloride tablets. DARU. 2008;16(2):60–9.
Desai KGH, Kumar TMP. Preparation and evaluation of a novel buccal adhesive system. AAP PharmSciTech. 2004;5(3):35.
Agarwal V, Mishra B. Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm. 1999;25(6):701–9.
Perioli L, Ambrogi V, Angelici A, Ricci M. Development of mucoadhesive patches for buccal administration of ibuprofen. J Control Release. 2004;99(1):73–82.
Okamoto H, Nakamori T, Arakawa Y, Iida K, Danjo K. Development of polymer film dosage forms of lidocaine for buccal administration: II. Comparison of preparation methods. J Pharm Sci. 2002;91(11):2424–32.
Abu-Huwaij R, Assaf S, Salem M, Sallam A. Potential mucoadhesive dosage form of lidocaine hydrochloride: I. Mucoadhesive and physicochemical characterization. Drug Dev Ind Pharm. 2007;33(8):855–64.
Harding S. Mucoadhesive interactions. Biochem Soc Trans. 2003;31(5):1036–42.
Ceulemans J, Vinckier I, Ludwig A. The use of xanthan gum in an ophthalmic liquid dosage form: rheological characterization of the interaction with mucin. J Pharm Sci. 2002;91(4):1117–27.
Liabot J, Manzo R, Allemandi D. Double layered mucoadhesive tablets containing nystatin. AAPS PharmSciTech. 2002;3(3):22.
Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57:1666–91.
Guo J. Bioadhesive polymer buccal patches for buprenorphine controlled delivery: formulation, in vitro adhesion and release properties. Drug Dev Ind Pharm. 1994;20(18):2809–21.
Richardson RK, Ross-Murphy SB. Non-linear viscoelasticity of polysaccharide solutions. 2: xanthan polysaccharide solutions. Int J Biol Macromol. 1987;9:257–64.
Lopez C, Portero A, Jato J, Alonso M. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release. 1998;55:143–52.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editors: Michael Repka, Joseph Reo, Linda Felton, and Stephen Howard
Rights and permissions
About this article
Cite this article
Abu-Huwaij, R., Obaidat, R.M., Sweidan, K. et al. Formulation and In Vitro Evaluation of Xanthan Gum or Carbopol 934-Based Mucoadhesive Patches, Loaded with Nicotine. AAPS PharmSciTech 12, 21–27 (2011). https://doi.org/10.1208/s12249-010-9534-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-010-9534-5